Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × Melphalan × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 7 Multiple Myeloma 6 Hematologic Neoplasms 6 Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Neuroblastoma 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Hematologic Diseases 4 Leukemia, B-Cell 3 Hodgkin Disease 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myeloproliferative Disorders 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2

Interventions

Nivolumab 3 Ipilimumab 2 tremelimumab 1 relatlimab 1 Opdualag 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡